GE HealthCare Technologies Inc.
GEHC
Xếp hạng trong cổ phiếu
#770
GE HealthCare Technologies Inc. is a global medical technology company that... GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Giá cổ phiếu
$69.03
Vốn hóa thị trường
$31.18B
Thay đổi (1 ngày)
-1.71%
Thay đổi (1 năm)
-9.29%
Quốc gia
US
Giao dịch GE HealthCare Technologies Inc. (GEHC)
Danh mục
Healthcare
Doanh thu của GE HealthCare Technologies Inc. (GEHC)
Doanh thu vào Jun 2026 TTM: $20.24B
Theo các báo cáo tài chính gần đây của GE HealthCare Technologies Inc., doanh thu hiện tại của công ty (TTM) là $20.24B. Trong năm 2024, công ty đạt doanh thu $19.67B tăng so với doanh thu năm 2023, là $19.55B. Doanh thu là tổng số tiền công ty tạo ra từ việc bán hàng hóa hoặc dịch vụ. Không giống như lợi nhuận, doanh thu không trừ chi phí.
Lịch sử doanh thu của GE HealthCare Technologies Inc. từ 2019 đến 2026
Doanh thu vào cuối mỗi năm
| Năm | Doanh thu | Thay đổi |
|---|---|---|
| 2026 (TTM) | $20.24B | -1.85% |
| 2025 | $20.63B | 4.84% |
| 2024 | $19.67B | 0.61% |
| 2023 | $19.55B | 6.60% |
| 2022 | $18.34B | 4.30% |
| 2021 | $17.59B | 2.45% |
| 2020 | $17.16B | 3.19% |
| 2019 | $16.63B | 0.00% |
Doanh thu của các công ty hoặc đối thủ tương tự
| Công ty | Doanh thu | Chênh lệch doanh thu | Quốc gia |
|---|---|---|---|
| $184.56M | -99.09% |
AU
|
|
| $14.37B | -29.00% |
US
|
|
| $1.43B | -92.93% |
US
|
|
| $616.91M | -96.95% |
US
|
|
| - | - |
US
|
